ATX amplia therapeutics limited

The AACR 2026 abstract tabulated below presents 1L combination...

  1. 203 Posts.
    lightbulb Created with Sketch. 386
    The AACR 2026 abstract tabulated below presents 1L combination of daraxonrasib and GnP. Encouraging results, despite the safety profile, deemed manageable, revealing increased toxicity to the regimen.

    https://acrobat.adobe.com/id/urn:aaid:sc:AP:4a8ad0cd-8e5b-
    4aea-af88-36a82241d280

    https://hotcopper.com.au/data/attachments/7827/7827216-3b2d4fb803c13484c51b0191603ea0e4.jpg
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.